- Home
- ALDX vs MCR Comparison
ALDX vs MCR Comparison
Compare ALDX & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- MCR
- Stock Information
- Founded
- ALDX 2004
- MCR 1989
- Country
- ALDX United States
- MCR United States
- Employees
- ALDX N/A
- MCR N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- ALDX Health Care
- MCR Finance
- Exchange
- ALDX Nasdaq
- MCR Nasdaq
- Market Cap
- ALDX 296.0M
- MCR 263.1M
- IPO Year
- ALDX 2014
- MCR N/A
- Fundamental
- Price
- ALDX $4.72
- MCR $6.35
- Analyst Decision
- ALDX Strong Buy
- MCR
- Analyst Count
- ALDX 2
- MCR 0
- Target Price
- ALDX $9.50
- MCR N/A
- AVG Volume (30 Days)
- ALDX 625.1K
- MCR 66.7K
- Earning Date
- ALDX 11-05-2025
- MCR 01-01-0001
- Dividend Yield
- ALDX N/A
- MCR 8.52%
- EPS Growth
- ALDX N/A
- MCR N/A
- EPS
- ALDX N/A
- MCR 0.38
- Revenue
- ALDX N/A
- MCR N/A
- Revenue This Year
- ALDX N/A
- MCR N/A
- Revenue Next Year
- ALDX $63.48
- MCR N/A
- P/E Ratio
- ALDX N/A
- MCR $16.61
- Revenue Growth
- ALDX N/A
- MCR N/A
- 52 Week Low
- ALDX $1.14
- MCR $5.63
- 52 Week High
- ALDX $7.20
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- ALDX 34.90
- MCR 45.49
- Support Level
- ALDX $4.85
- MCR $6.28
- Resistance Level
- ALDX $5.27
- MCR $6.38
- Average True Range (ATR)
- ALDX 0.27
- MCR 0.07
- MACD
- ALDX -0.05
- MCR 0.00
- Stochastic Oscillator
- ALDX 14.15
- MCR 30.00
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.